Outset Medical Inc (OM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Outset Medical Inc (OM) has a cash flow conversion efficiency ratio of -0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.32 Million) by net assets ($142.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Outset Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Outset Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read OM current and long-term liabilities for a breakdown of total debt and financial obligations.
Outset Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Outset Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Seafco Public Company Limited
BK:SEAFCO
|
0.073x |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
0.037x |
|
Global Fashion Group SA
XETRA:GFG
|
-0.160x |
|
Premium Snacks Nordic AB
ST:SNX
|
0.028x |
|
Careium AB
ST:CARE
|
0.102x |
|
Thorney Opportunities Ltd
AU:TOP
|
-0.036x |
|
IZEA Inc
NASDAQ:IZEA
|
0.024x |
|
S Chand And Company Limited
NSE:SCHAND
|
-0.061x |
Annual Cash Flow Conversion Efficiency for Outset Medical Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Outset Medical Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see OM stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $126.95 Million | $-46.33 Million | -0.365x | +91.59% |
| 2024-12-31 | $26.82 Million | $-116.30 Million | -4.337x | -305.64% |
| 2023-12-31 | $122.89 Million | $-131.37 Million | -1.069x | -80.46% |
| 2022-12-31 | $245.99 Million | $-145.73 Million | -0.592x | -70.13% |
| 2021-12-31 | $374.08 Million | $-130.26 Million | -0.348x | -15.57% |
| 2020-12-31 | $328.61 Million | $-99.02 Million | -0.301x | -259.54% |
| 2019-12-31 | $-372.19 Million | $-70.29 Million | 0.189x | +17.10% |
| 2018-12-31 | $-287.95 Million | $-46.44 Million | 0.161x | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, … Read more